Shilpa Medicare Ltd. (SHILPAMED) Share Price Hits New 52-Week High

Shilpa Medicare Ltd. Share Price surged to a new 52-week high of Rs 786.55, marking a 7.85% increase today. The market capitalisation stands at Rs 12,681.52 crore.

Shilpa Medicare Ltd. Share Price has reached a fresh 52-week high of Rs 786.55, reflecting a significant 7.85% rise from the previous close of Rs 721.35. The company's market capitalisation now stands at Rs 12,681.52 crore, highlighting its substantial presence in the healthcare sector. This remarkable price movement underscores investor interest, although the data does not specify a company-specific catalyst for this surge. Investors and analysts are closely monitoring Shilpa Medicare Ltd. as it navigates this new price territory.

Shilpa Medicare Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 778
Previous Close	Rs 721.35
Today's Change	+Rs 56.65 (+7.85%)
Day Open	Rs 738
Fresh 52-Week High	Rs 786.55
Day Low	Rs 737.95
Current Volume	5,57,125
Turnover	Rs 43.34 crore
Market Capitalisation	Rs 12,681.52 crore

Shilpa Medicare Ltd. (SHILPAMED) traded at Rs 778. versus the previous close of Rs 721.35, a rise of 7.85%. The stock opened at Rs 738, reached Rs 786.55, touched Rs 737.95. Reported volume was 5,57,125.

Today, Shilpa Medicare Ltd. opened at Rs 738 and quickly climbed to a high of Rs 786.55, setting a new 52-week peak. The stock closed at Rs 778, marking a day change of Rs 56.65 or 7.85%. The day's low was Rs 737.95, with a turnover of Rs 43.34 crore. Volume participation was robust, with 5,57,125 shares traded, indicating heightened investor activity. This price action suggests strong market interest, setting the stage for further analysis of the company's fundamentals and sector positioning.

Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 12,681.52 crore
P/E Ratio	31.4x
P/B Ratio	0.46x
ROE	-2.89%
ROCE	-0.26%

Shilpa Medicare Ltd. was valued at a P/E ratio of 31.4x, a P/B ratio of 0.46x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.4x
Benchmark Median P/E	21.61x
Benchmark Average P/E	72.01x
Benchmark P/E Range	0x to 3,428.55x
Company P/B Ratio	0.46x
Benchmark Median P/B	1.92x
Company ROE	-2.89%
Benchmark Median ROE	10.75%
Company ROCE	-0.26%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 12,681.52 crore
Benchmark Median Market Cap	Rs 139.72 crore

Shilpa Medicare Ltd. (SHILPAMED) is classified under sector: Healthcare.

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 31.4x, which is above the benchmark median of 21.61x, a difference of +45.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Shilpa Medicare Ltd. (SHILPAMED) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,943.6	31.4	0.46	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,684.11	39.39	8.02	28.21	26.35
Beta Drugs Ltd.	BETA	2,621.81	63.25	10.01	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,511.89	32.96	6.79	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,347.02	160.63	2.97	13.9	12.97

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 31.4x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 12,681.52 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Shilpa Medicare Ltd.

• Shilpa Medicare Ltd. Share Price hit a new 52-week high, indicating strong market interest.
• The company's valuation metrics present a mixed picture, with a high P/E ratio but low P/B ratio.
• Negative profitability metrics warrant cautious observation by investors.
• Sector comparison shows Shilpa Medicare's large market cap relative to peers.

About Shilpa Medicare Ltd.

Shilpa Medicare Ltd. operates in the healthcare sector, focusing on pharmaceuticals and drugs. The company is known for its diverse product portfolio, catering to various therapeutic areas. With a significant market presence, Shilpa Medicare Ltd. continues to expand its operations and strengthen its position in the industry. Its commitment to innovation and quality has been a driving force behind its growth.

Track Shilpa Medicare Ltd. Share Price on Univest

Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Shilpa Medicare Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest. Stay informed with real-time data and analysis.

Frequently Asked Questions

What is the current share price of Shilpa Medicare Ltd.?

Ans. The current share price of Shilpa Medicare Ltd. is Rs 778, following a 7.85% increase today, reaching a new 52-week high of Rs 786.55. The stock moved 7.85% during the session.

What is Shilpa Medicare Ltd.'s market capitalisation?

Ans. Shilpa Medicare Ltd.'s market capitalisation is Rs 12,681.52 crore, reflecting its substantial size within the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 31.4x. ROE is -2.89% and ROCE is -0.26%.

How does Shilpa Medicare Ltd.'s P/E ratio compare to the sector?

Ans. Shilpa Medicare Ltd.'s P/E ratio of 31.4 is above the sector median of 21.61, indicating a relatively higher valuation compared to its sector peers. The company trades at a P/E ratio of 31.4x.

What are Shilpa Medicare Ltd.'s profitability metrics?

Ans. Shilpa Medicare Ltd. reports a negative ROE of -2.89% and a negative ROCE of -0.26%, suggesting challenges in profitability and capital efficiency. ROE stands at -2.89%. ROCE stands at -0.26%.

How does Shilpa Medicare Ltd.'s P/B ratio compare to the sector?

Ans. The company's P/B ratio of 0.46 is significantly below the sector median of 1.92, indicating a potentially undervalued position in terms of book value. The company trades at a P/E ratio of 31.4x.

Who are Shilpa Medicare Ltd.'s peers?

Ans. Peers include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Beta Drugs Ltd., among others, within the healthcare sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.

What is the significance of the 52-week high for Shilpa Medicare Ltd.?

Ans. The 52-week high of Rs 786.55 signifies strong market interest and investor confidence in Shilpa Medicare Ltd.'s stock performance. The stock moved 7.85% during the session. The intraday range extended from Rs 737.95 to Rs 786.55.

How does Shilpa Medicare Ltd.'s market cap compare to its peers?

Ans. Shilpa Medicare Ltd.'s market cap of Rs 12,681.52 crore is significantly larger than its peers, indicating its dominant position in the sector. The company operates in the Healthcare sector. Its P/E ratio is 31.4x.

Where can I track Shilpa Medicare Ltd.'s share price?

Ans. You can track Shilpa Medicare Ltd.'s share price, technical indicators, and market insights on Univest for real-time data and analysis. The stock moved 7.85% during the session. The intraday range extended from Rs 737.95 to Rs 786.55.